Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
20 active Medicare policies list M48.52XD, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
J9 · Effective Aug 11, 2024
JH · Effective Aug 11, 2024
JL · Effective Aug 11, 2024
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M48.52XD |
|---|---|---|
| Intraoperative Monitoring | Sep 15, 2025 | Covered |
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
JL · Effective Apr 9, 2026
J9 · Effective Apr 9, 2026
National · Effective Oct 1, 2026
National · Effective Aug 6, 2026